Laura Farmer, SVP, Business Development and Marketing

Laura Farmer leads business development and marketing for Real Endpoints and its subsidiary, Reimbursement Intelligence. Ms. Farmer brings over twenty years of life science experience with a background in strategy consulting and competitive intelligence.

Most recently, Ms. Farmer served as Executive Vice President at Larvol where she built out and led the Pharmaceutical Solutions Division and secured key relationships with over 20 of the top 25 global pharmaceutical companies. In this role, she established and oversaw all sales, business development, and client management operations, set strategic direction, and was heavily involved in the evolution of Larvol’s key competitive intelligence products.

Prior to joining Larvol, Ms. Farmer sold and led a wide range of strategy, marketing, and commercialization projects as a management consultant in the biopharmaceutical industry. She has worked with Business Talent Group, Straticore, Insight Strategy Advisors (Publicis Healthcare), True North Partners, CSC Healthcare, and The Wilkerson Group (IBM Consulting) for top pharmaceutical and biotech firms. Ms. Farmer advised numerous global pharmaceutical and medical device companies and helped them achieve revenue growth through delivering opportunity assessments, licensing strategies, brand and launch plans, go-to-market strategies, and more.

Ms. Farmer has a BA in pre-medical studies and Political Science with distinction from Yale University.

Our Team

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare -- with executive committee and....

read full biography >

Susan Raiola


Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Roger Longman


Mr. Longman is recognized as an expert in biopharmaceutical strategy and reimbursement and often speaks at key...

read full biography >

Norman Selby

Vice Chairman

Norman C. Selby has spent 35 years in the healthcare world in a variety of consulting, managerial, investor and Board roles...

read full biography >

Jane F. Barlow, MD, MPH, MBA

EVP & Chief Clinical Officer

Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership...

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Laura Farmer

SVP, Business Development and Marketing

Laura Farmer leads business development and marketing for Real Endpoints and subsidiary, Reimbursement Intelligence...

read full biography >

Heather Ritchie

VP, Product Strategy and Development

Heather Ritchie is VP Product Strategy and Development at Real Endpoints. She works closely with our customers and partners...

read full biography >

Jane Borne, RPh

VP, Pharmacy

Jane Borne, RPh, is responsible for ensuring the clinical credibility and evidence basis of all RE drug evaluation activities...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >